| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone binding | 2.82e-08 | 265 | 70 | 10 | GO:0042393 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 8.38e-06 | 37 | 70 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 2.28e-04 | 34 | 70 | 3 | GO:0046966 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 7.82e-04 | 206 | 70 | 5 | GO:0140030 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.03e-03 | 127 | 70 | 4 | GO:0008094 | |
| GeneOntologyMolecularFunction | histone chaperone activity | 1.24e-03 | 15 | 70 | 2 | GO:0140713 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.25e-03 | 229 | 70 | 5 | GO:0140993 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | USP36 SART3 ARID4B VPS72 ATRX BRPF1 BRD7 NAP1L1 NSD1 NAP1L4 CHD8 CHD3 ZDBF2 KMT2E IFI16 JMJD1C | 1.68e-09 | 741 | 68 | 16 | GO:0006338 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | USP36 SART3 MED19 ARID4B VPS72 ATRX BRPF1 BRD7 NAP1L1 NSD1 NAP1L4 CHD8 CHD3 ZDBF2 KMT2E IFI16 JMJD1C | 1.69e-08 | 999 | 68 | 17 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin organization | USP36 SART3 ARID4B VPS72 ATRX BRPF1 BRD7 NAP1L1 NSD1 NAP1L4 CHD8 CHD3 ZDBF2 KMT2E IFI16 JMJD1C | 2.48e-08 | 896 | 68 | 16 | GO:0006325 |
| GeneOntologyBiologicalProcess | ribosomal small subunit biogenesis | 6.61e-08 | 108 | 68 | 7 | GO:0042274 | |
| GeneOntologyBiologicalProcess | ribosome biogenesis | 1.54e-06 | 336 | 68 | 9 | GO:0042254 | |
| GeneOntologyBiologicalProcess | ribonucleoprotein complex biogenesis | 6.85e-06 | 515 | 68 | 10 | GO:0022613 | |
| GeneOntologyBiologicalProcess | rRNA processing | 1.06e-05 | 230 | 68 | 7 | GO:0006364 | |
| GeneOntologyBiologicalProcess | maturation of SSU-rRNA | 3.25e-05 | 55 | 68 | 4 | GO:0030490 | |
| GeneOntologyBiologicalProcess | rRNA metabolic process | 3.36e-05 | 275 | 68 | 7 | GO:0016072 | |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | 1.06e-04 | 330 | 68 | 7 | GO:0040029 | |
| GeneOntologyBiologicalProcess | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.46e-04 | 37 | 68 | 3 | GO:0000462 | |
| GeneOntologyCellularComponent | preribosome | 3.76e-05 | 114 | 69 | 5 | GO:0030684 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 1.80e-04 | 85 | 69 | 4 | GO:0000118 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | SART3 MED19 ARID4B PRPF40B POP1 BRD7 NSD1 PRPF38B CHD8 CHD3 KMT2E JMJD1C MED12 | 5.02e-04 | 1377 | 69 | 13 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear body | 7.24e-04 | 903 | 69 | 10 | GO:0016604 | |
| GeneOntologyCellularComponent | cytoplasmic ubiquitin ligase complex | 9.52e-04 | 14 | 69 | 2 | GO:0000153 | |
| GeneOntologyCellularComponent | chromatin | ARID4B VPS72 ATRX ZBED6 BRPF1 BRD7 NAP1L1 NSD1 NAP1L4 CHD8 CHD3 KMT2E JMJD1C | 9.86e-04 | 1480 | 69 | 13 | GO:0000785 |
| Domain | BROMODOMAIN_1 | 9.69e-06 | 37 | 68 | 4 | PS00633 | |
| Domain | Bromodomain | 1.08e-05 | 38 | 68 | 4 | PF00439 | |
| Domain | BROMODOMAIN_2 | 1.47e-05 | 41 | 68 | 4 | PS50014 | |
| Domain | BROMO | 1.62e-05 | 42 | 68 | 4 | SM00297 | |
| Domain | Bromodomain | 1.62e-05 | 42 | 68 | 4 | IPR001487 | |
| Domain | - | 1.62e-05 | 42 | 68 | 4 | 1.20.920.10 | |
| Domain | ZF_PHD_2 | 2.48e-05 | 95 | 68 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 2.61e-05 | 96 | 68 | 5 | PS01359 | |
| Domain | Zinc_finger_PHD-type_CS | 9.20e-05 | 65 | 68 | 4 | IPR019786 | |
| Domain | Znf_PHD-finger | 1.97e-04 | 79 | 68 | 4 | IPR019787 | |
| Domain | Znf_FYVE_PHD | 1.97e-04 | 147 | 68 | 5 | IPR011011 | |
| Domain | SNF2_N | 2.12e-04 | 32 | 68 | 3 | IPR000330 | |
| Domain | Chromodomain-like | 2.12e-04 | 32 | 68 | 3 | IPR016197 | |
| Domain | SNF2_N | 2.12e-04 | 32 | 68 | 3 | PF00176 | |
| Domain | Chromo/shadow_dom | 2.33e-04 | 33 | 68 | 3 | IPR000953 | |
| Domain | CHROMO | 2.33e-04 | 33 | 68 | 3 | SM00298 | |
| Domain | PHD | 3.11e-04 | 89 | 68 | 4 | SM00249 | |
| Domain | Znf_PHD | 3.38e-04 | 91 | 68 | 4 | IPR001965 | |
| Domain | - | 1.21e-03 | 449 | 68 | 7 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 1.38e-03 | 459 | 68 | 7 | IPR013083 | |
| Domain | NAP | 1.71e-03 | 17 | 68 | 2 | PF00956 | |
| Domain | NAP_family | 1.71e-03 | 17 | 68 | 2 | IPR002164 | |
| Domain | GTP_binding_domain | 2.15e-03 | 19 | 68 | 2 | IPR006073 | |
| Domain | PWWP | 2.38e-03 | 20 | 68 | 2 | SM00293 | |
| Domain | PHD | 2.58e-03 | 75 | 68 | 3 | PF00628 | |
| Domain | PWWP | 3.15e-03 | 23 | 68 | 2 | PF00855 | |
| Domain | PWWP_dom | 3.15e-03 | 23 | 68 | 2 | IPR000313 | |
| Domain | PWWP | 3.42e-03 | 24 | 68 | 2 | PS50812 | |
| Domain | Chromo_domain | 3.42e-03 | 24 | 68 | 2 | IPR023780 | |
| Domain | Bromodomain_CS | 4.01e-03 | 26 | 68 | 2 | IPR018359 | |
| Domain | Chromo | 4.01e-03 | 26 | 68 | 2 | PF00385 | |
| Domain | CHROMO_1 | 4.64e-03 | 28 | 68 | 2 | PS00598 | |
| Domain | CHROMO_2 | 4.64e-03 | 28 | 68 | 2 | PS50013 | |
| Domain | Helicase_C | 6.99e-03 | 107 | 68 | 3 | PF00271 | |
| Domain | HELICc | 6.99e-03 | 107 | 68 | 3 | SM00490 | |
| Domain | Helicase_C | 7.18e-03 | 108 | 68 | 3 | IPR001650 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 7.19e-03 | 35 | 68 | 2 | IPR002464 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 4.87e-05 | 65 | 44 | 4 | M39682 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION | 9.80e-05 | 29 | 44 | 3 | MM15340 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION | 1.09e-04 | 30 | 44 | 3 | M27637 | |
| Pathway | REACTOME_MAJOR_PATHWAY_OF_RRNA_PROCESSING_IN_THE_NUCLEOLUS_AND_CYTOSOL | 2.33e-04 | 180 | 44 | 5 | MM15324 | |
| Pathway | REACTOME_RRNA_PROCESSING | 4.24e-04 | 205 | 44 | 5 | M27685 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | USP36 SART3 MED19 ARID4B VPS72 ATRX RSL1D1 ZNF644 BRD7 NSD1 KRI1 AATF CHD8 CHD3 ZDBF2 KRR1 JMJD1C PHIP GNL3 RPS27L KNOP1 | 1.39e-16 | 954 | 70 | 21 | 36373674 |
| Pubmed | USP36 SART3 MED19 VPS72 ATRX ZBED6 TRIM56 POP1 BRD7 BMS1 NAP1L1 NSD1 NAP1L4 OS9 AATF PRPF38B CHD8 KRR1 ZBTB11 SYT7 MED12 GNL3 RPS27L KNOP1 | 7.13e-16 | 1497 | 70 | 24 | 31527615 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | GTPBP4 UBE2O ARID4B ATRX NKAPD1 ZNF644 BRPF1 BRD7 FAM169A NSD1 CHD8 CHD3 ZBTB11 JMJD1C PHIP GNL3 KNOP1 | 3.56e-15 | 608 | 70 | 17 | 36089195 |
| Pubmed | SART3 GTPBP4 LONP1 UBE2O RSL1D1 POP1 BMS1 NAP1L1 NSD1 KRI1 AATF CHD8 KRR1 ZBTB11 PHIP MED12 GNL3 | 1.14e-14 | 653 | 70 | 17 | 22586326 | |
| Pubmed | SART3 GTPBP4 TXLNA RIOK1 MED19 RSL1D1 NKAPD1 TRIM56 POP1 BRD7 BMS1 NAP1L1 MRPS33 KRI1 AATF PRPF38B CHD3 NKTR KRR1 AP3D1 GNL3 KNOP1 | 1.52e-14 | 1371 | 70 | 22 | 36244648 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | USP36 GTPBP4 LONP1 RSL1D1 POP1 BRD7 KRI1 CHD8 CHD3 IFI16 MED12 GNL3 RPS27L KNOP1 | 8.52e-14 | 410 | 70 | 14 | 26949251 |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | USP36 GTPBP4 ATRX RSL1D1 POP1 BMS1 KRI1 AATF KRR1 IFI16 PHIP GNL3 KNOP1 | 2.38e-13 | 349 | 70 | 13 | 25665578 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | GTPBP4 LONP1 RIOK1 MED19 RSL1D1 NKAPD1 POP1 BMS1 NAP1L1 KRI1 AATF PRPF38B CHD8 NKTR KRR1 PHIP AP3D1 GNL3 RPS27L KNOP1 | 8.62e-13 | 1318 | 70 | 20 | 30463901 |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | GTPBP4 ZNF22 RSL1D1 POP1 BMS1 NAP1L1 KRI1 CHD3 NKTR KRR1 PHIP GNL3 | 2.84e-12 | 330 | 70 | 12 | 33301849 |
| Pubmed | USP36 SART3 GTPBP4 TRIM56 POP1 BMS1 KRI1 AATF KRR1 IFI16 PHIP GNL3 | 3.04e-12 | 332 | 70 | 12 | 25693804 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | GTPBP4 TXLNA ARID4B RSL1D1 POP1 BMS1 KRI1 AATF CHD3 KRR1 ZBTB11 AP3D1 MED12 GNL3 KNOP1 | 2.51e-11 | 759 | 70 | 15 | 35915203 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | USP36 SART3 GTPBP4 RIOK1 UBE2O ATRX RSL1D1 FAM169A NAP1L1 NAP1L4 PRPF38B CHD3 SIPA1L2 AP3D1 GNL3 KNOP1 | 4.12e-11 | 934 | 70 | 16 | 33916271 |
| Pubmed | SART3 GTPBP4 TXLNA UBE2O COCH ATRX RSL1D1 ZNF644 POP1 BMS1 MRPS33 NAP1L4 KRI1 OS9 TTC17 SIPA1L2 AP3D1 GNL3 USP33 | 6.89e-11 | 1487 | 70 | 19 | 33957083 | |
| Pubmed | GTPBP4 ZNF22 RSL1D1 POP1 BMS1 NAP1L1 MRPS33 KRI1 PRPF38B NKTR KRR1 GNL3 RPS27L KNOP1 | 1.37e-10 | 713 | 70 | 14 | 29802200 | |
| Pubmed | GTPBP4 LONP1 UBE2O ARID4B VPS72 ATRX RSL1D1 ZNF644 BRD7 BMS1 MRPS33 NAP1L4 KRI1 CHD8 CHD3 KRR1 JMJD1C GNL3 | 3.05e-10 | 1429 | 70 | 18 | 35140242 | |
| Pubmed | USP36 GTPBP4 ARID4B VPS72 PRPF40B TRIM56 BRPF1 BRD7 CHD8 CHD3 SIPA1L2 SYT7 PHIP GNL3 BRWD3 KNOP1 | 5.54e-10 | 1116 | 70 | 16 | 31753913 | |
| Pubmed | The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival. | 6.41e-10 | 220 | 70 | 9 | 31822558 | |
| Pubmed | SART3 GTPBP4 TXLNA RIOK1 UBE2O ARID4B RSL1D1 POP1 BMS1 FAM169A NAP1L1 KRI1 KRR1 ZBTB11 GNL3 | 7.56e-10 | 971 | 70 | 15 | 33306668 | |
| Pubmed | SART3 GTPBP4 UBE2O USF3 RSL1D1 POP1 NAP1L1 MRPS33 NAP1L4 KRI1 IFIT5 CHD8 CHD3 KRR1 GNL3 RPS27L | 8.86e-10 | 1153 | 70 | 16 | 29845934 | |
| Pubmed | SART3 GTPBP4 RIOK1 RSL1D1 TRIM56 POP1 IFIT5 AATF CHD3 KRR1 GNL3 | 9.04e-10 | 425 | 70 | 11 | 21081503 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | USP36 SART3 GTPBP4 LONP1 RSL1D1 POP1 BMS1 NAP1L1 AATF CHD8 KRR1 IFI16 PHIP AP3D1 MED12 GNL3 RPS27L | 1.08e-09 | 1353 | 70 | 17 | 29467282 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SART3 GTPBP4 VPS72 ATRX RSL1D1 POP1 BRD7 AATF CHD8 NKTR ZBTB11 | 1.30e-09 | 440 | 70 | 11 | 34244565 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | USP36 SART3 GTPBP4 LONP1 TXLNA RIOK1 UBE2O GUCY1B2 ATRX RSL1D1 VPS13C BMS1 NAP1L1 KRI1 KRR1 PHIP GNL3 | 2.36e-09 | 1425 | 70 | 17 | 30948266 |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 2.68e-09 | 259 | 70 | 9 | 30404004 | |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | 3.17e-09 | 364 | 70 | 10 | 24778252 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | USP36 GTPBP4 ARID4B VPS72 ATRX RSL1D1 ZNF644 POP1 NSD1 AATF CHD3 NKTR IFI16 JMJD1C GNL3 KNOP1 | 4.59e-09 | 1294 | 70 | 16 | 30804502 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 5.80e-09 | 283 | 70 | 9 | 30585729 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 6.74e-09 | 394 | 70 | 10 | 27248496 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | GTPBP4 MED19 ATRX NSD1 AATF CHD8 TTC17 CHD3 ZBTB11 PHIP GNL3 | 9.46e-09 | 533 | 70 | 11 | 30554943 |
| Pubmed | SART3 LONP1 RIOK1 UBE2O POP1 NAP1L1 MRPS33 NAP1L4 KRI1 AP3D1 GNL3 | 1.23e-08 | 547 | 70 | 11 | 37267103 | |
| Pubmed | GTPBP4 RSL1D1 BRPF1 POP1 BMS1 NAP1L1 KRI1 AATF CHD3 KRR1 IFI16 RPS27L KNOP1 | 1.28e-08 | 847 | 70 | 13 | 35850772 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 2.10e-08 | 148 | 70 | 7 | 32538781 | |
| Pubmed | 2.76e-08 | 339 | 70 | 9 | 30415952 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | USP36 GTPBP4 RSL1D1 BMS1 KRI1 AATF CHD3 KRR1 GNL3 RPS27L KNOP1 | 3.45e-08 | 605 | 70 | 11 | 28977666 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | GTPBP4 LONP1 RSL1D1 VPS13C ZNF644 BRD7 BMS1 FAM169A MRPS33 AATF TTC17 ZDBF2 PHIP GNL3 USP33 RPS27L | 3.49e-08 | 1496 | 70 | 16 | 32877691 |
| Pubmed | 4.58e-08 | 483 | 70 | 10 | 36912080 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 4.92e-08 | 256 | 70 | 8 | 33397691 | |
| Pubmed | GTPBP4 RIOK1 UBE2O RSL1D1 BRD7 NAP1L1 NAP1L4 KRR1 GNL3 RPS27L | 5.34e-08 | 491 | 70 | 10 | 36273042 | |
| Pubmed | TXLNA RIOK1 UBE2O MED19 ARID4B VPS72 RSL1D1 FAM169A IFIT5 PHIP MED12 | 6.59e-08 | 645 | 70 | 11 | 25281560 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | SART3 GTPBP4 UBE2O RSL1D1 TRIM56 BMS1 NAP1L1 IFIT5 AATF KRR1 GNL3 RPS27L | 6.97e-08 | 807 | 70 | 12 | 22681889 |
| Pubmed | SART3 TXLNA RIOK1 ATRX POP1 CHD8 CHD3 ZBTB11 JMJD1C AP3D1 USP33 | 7.12e-08 | 650 | 70 | 11 | 38777146 | |
| Pubmed | 7.77e-08 | 106 | 70 | 6 | 12429849 | ||
| Pubmed | 1.03e-07 | 282 | 70 | 8 | 23667531 | ||
| Pubmed | SART3 GTPBP4 LONP1 MED19 ATRX NAP1L1 NAP1L4 PRPF38B CHD8 CHD3 IFI16 MED12 GNL3 | 1.04e-07 | 1014 | 70 | 13 | 32416067 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | SART3 GTPBP4 LONP1 RIOK1 RSL1D1 POP1 NAP1L1 KRI1 KRR1 GNL3 RPS27L | 1.09e-07 | 678 | 70 | 11 | 30209976 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SART3 GTPBP4 LONP1 TXLNA RIOK1 UBE2O RSL1D1 POP1 NAP1L1 MRPS33 NAP1L4 KRI1 KRR1 AP3D1 GNL3 | 1.13e-07 | 1415 | 70 | 15 | 28515276 |
| Pubmed | SART3 GTPBP4 LONP1 RSL1D1 POP1 BMS1 NAP1L1 MRPS33 NAP1L4 KRI1 OS9 KRR1 IFI16 AP3D1 RPS27L | 1.42e-07 | 1440 | 70 | 15 | 30833792 | |
| Pubmed | 1.60e-07 | 417 | 70 | 9 | 36537216 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | SART3 GTPBP4 TXLNA RSL1D1 TRIM56 POP1 BMS1 NAP1L1 KRI1 AATF KRR1 IFI16 GNL3 KNOP1 | 1.76e-07 | 1257 | 70 | 14 | 36526897 |
| Pubmed | 2.15e-07 | 208 | 70 | 7 | 11790298 | ||
| Pubmed | GTPBP4 RSL1D1 BMS1 NAP1L1 MRPS33 KRI1 PRPF38B KRR1 GNL3 RPS27L KNOP1 | 2.30e-07 | 731 | 70 | 11 | 29298432 | |
| Pubmed | 4.29e-07 | 469 | 70 | 9 | 27634302 | ||
| Pubmed | Mechanism of client selection by the protein quality-control factor UBE2O. | 4.34e-07 | 8 | 70 | 3 | 35915257 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 4.38e-07 | 341 | 70 | 8 | 32971831 | |
| Pubmed | 4.77e-07 | 234 | 70 | 7 | 36243803 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | USP36 GTPBP4 RSL1D1 POP1 BMS1 NAP1L1 KRI1 AATF KRR1 ZBTB11 JMJD1C GNL3 | 6.11e-07 | 989 | 70 | 12 | 36424410 |
| Pubmed | 7.32e-07 | 653 | 70 | 10 | 33742100 | ||
| Pubmed | SART3 GTPBP4 ZNF22 RSL1D1 TRIM56 POP1 NAP1L1 CHD3 ZBTB11 GNL3 | 7.53e-07 | 655 | 70 | 10 | 35819319 | |
| Pubmed | 8.05e-07 | 253 | 70 | 7 | 29911972 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | SART3 GTPBP4 TXLNA RSL1D1 NAP1L1 MRPS33 NAP1L4 PRPF38B CHD3 AP3D1 RPS27L | 9.80e-07 | 847 | 70 | 11 | 35235311 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | LONP1 TXLNA RIOK1 VPS13C BRPF1 NAP1L1 NAP1L4 KRI1 TTC17 SIPA1L2 GNL3 | 1.05e-06 | 853 | 70 | 11 | 28718761 |
| Pubmed | 2.01e-06 | 418 | 70 | 8 | 34709266 | ||
| Pubmed | 2.04e-06 | 419 | 70 | 8 | 15635413 | ||
| Pubmed | SART3 LONP1 RIOK1 UBE2O RSL1D1 POP1 NAP1L1 MRPS33 NAP1L4 CHD3 KRR1 GNL3 RPS27L | 2.29e-06 | 1335 | 70 | 13 | 29229926 | |
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 2.84e-06 | 109 | 70 | 5 | 33554859 | |
| Pubmed | 3.30e-06 | 601 | 70 | 9 | 33658012 | ||
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 3.51e-06 | 316 | 70 | 7 | 31665637 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 20002496 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 34076483 | ||
| Pubmed | 4.85e-06 | 332 | 70 | 7 | 37433992 | ||
| Pubmed | Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression. | 5.11e-06 | 56 | 70 | 4 | 26919559 | |
| Pubmed | 5.48e-06 | 57 | 70 | 4 | 29499938 | ||
| Pubmed | 5.55e-06 | 641 | 70 | 9 | 36057605 | ||
| Pubmed | 7.04e-06 | 496 | 70 | 8 | 31343991 | ||
| Pubmed | 9.64e-06 | 242 | 70 | 6 | 34011540 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 9.82e-06 | 370 | 70 | 7 | 22922362 | |
| Pubmed | ATRX RSL1D1 NKAPD1 POP1 NSD1 PHTF2 AATF CHD3 KRR1 ZMAT1 KNOP1 | 1.03e-05 | 1084 | 70 | 11 | 11544199 | |
| Pubmed | 1.12e-05 | 529 | 70 | 8 | 14621295 | ||
| Pubmed | 1.19e-05 | 251 | 70 | 6 | 28077445 | ||
| Pubmed | Nucleosome assembly proteins NAP1L1 and NAP1L4 modulate p53 acetylation to regulate cell fate. | 1.20e-05 | 3 | 70 | 2 | 31634504 | |
| Pubmed | Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12. | 1.20e-05 | 3 | 70 | 2 | 26891131 | |
| Pubmed | TXLNA RSL1D1 ZNF644 NAP1L1 NAP1L4 PRPF38B CHD8 CHD3 IFI16 JMJD1C MED12 | 1.21e-05 | 1103 | 70 | 11 | 34189442 | |
| Pubmed | SART3 ARID4B VPS72 ATRX TRIM56 BRD7 FAM169A PRPF38B CHD8 ZDBF2 NKTR MED12 | 1.24e-05 | 1327 | 70 | 12 | 32694731 | |
| Pubmed | Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics. | 1.25e-05 | 384 | 70 | 7 | 31059266 | |
| Pubmed | 1.45e-05 | 723 | 70 | 9 | 34133714 | ||
| Pubmed | 1.47e-05 | 549 | 70 | 8 | 38280479 | ||
| Pubmed | 1.54e-05 | 263 | 70 | 6 | 34702444 | ||
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | 1.60e-05 | 732 | 70 | 9 | 34732716 | |
| Pubmed | 1.61e-05 | 733 | 70 | 9 | 34672954 | ||
| Pubmed | 1.68e-05 | 157 | 70 | 5 | 30186101 | ||
| Pubmed | 1.79e-05 | 159 | 70 | 5 | 22751105 | ||
| Pubmed | 1.92e-05 | 78 | 70 | 4 | 25720964 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | GTPBP4 RIOK1 RSL1D1 POP1 NAP1L1 AATF IFI16 AP3D1 GNL3 RPS27L | 1.97e-05 | 949 | 70 | 10 | 36574265 |
| Pubmed | NAP-2: histone chaperone function and phosphorylation state through the cell cycle. | 2.39e-05 | 4 | 70 | 2 | 10764593 | |
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 28380328 | ||
| Pubmed | NAP1L1 regulates NF-κB signaling pathway acting on anti-apoptotic Mcl-1 gene expression. | 2.39e-05 | 4 | 70 | 2 | 28687276 | |
| Pubmed | Multiple controls regulate nucleostemin partitioning between nucleolus and nucleoplasm. | 2.39e-05 | 4 | 70 | 2 | 17158916 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.47e-05 | 774 | 70 | 9 | 15302935 | |
| Pubmed | A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition. | 2.62e-05 | 431 | 70 | 7 | 33660365 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 3.20e-05 | 1005 | 70 | 10 | 19615732 | |
| Interaction | ZNF330 interactions | USP36 GTPBP4 RIOK1 UBE2O ARID4B RSL1D1 ZNF644 BRPF1 BRD7 BMS1 FAM169A NAP1L1 NSD1 NAP1L4 KRI1 AATF CHD3 ZBTB11 PHIP GNL3 KNOP1 | 1.12e-18 | 446 | 69 | 21 | int:ZNF330 |
| Interaction | SRSF6 interactions | GTPBP4 ZNF22 RIOK1 UBE2O RSL1D1 TRIM56 POP1 BRD7 BMS1 MRPS33 KRI1 AATF PRPF38B CHD3 NKTR KRR1 ZBTB11 IFI16 GNL3 KNOP1 | 2.26e-16 | 503 | 69 | 20 | int:SRSF6 |
| Interaction | NUP43 interactions | USP36 ARID4B VPS72 RSL1D1 ZNF644 BMS1 FAM169A NSD1 KRI1 AATF CHD8 CHD3 ZDBF2 NKTR ZBTB11 IFI16 JMJD1C PHIP MED12 GNL3 KNOP1 | 1.01e-15 | 625 | 69 | 21 | int:NUP43 |
| Interaction | MAGEB2 interactions | USP36 GTPBP4 ZNF22 RSL1D1 NKAPD1 TRIM56 POP1 BRD7 BMS1 NSD1 KRI1 AATF CHD3 NKTR KRR1 ZBTB11 KNOP1 | 2.02e-15 | 349 | 69 | 17 | int:MAGEB2 |
| Interaction | NIFK interactions | USP36 GTPBP4 RIOK1 UBE2O ZNF273 RSL1D1 POP1 BRD7 BMS1 NSD1 KRI1 AATF CHD3 KRR1 ZBTB11 IFI16 GNL3 KNOP1 | 3.90e-15 | 431 | 69 | 18 | int:NIFK |
| Interaction | KRR1 interactions | USP36 GTPBP4 ZNF22 RIOK1 UBE2O RSL1D1 POP1 BMS1 KRI1 AATF CHD3 KRR1 ZBTB11 IFI16 GNL3 USP33 KNOP1 | 7.89e-15 | 379 | 69 | 17 | int:KRR1 |
| Interaction | RPL13 interactions | USP36 SART3 GTPBP4 ZNF22 RIOK1 UBE2O RSL1D1 TRIM56 POP1 BMS1 MRPS33 KRI1 IFIT5 AATF CHD3 NKTR ZBTB11 IFI16 GNL3 RPS27L KNOP1 | 9.51e-15 | 700 | 69 | 21 | int:RPL13 |
| Interaction | RPL17 interactions | USP36 SART3 GTPBP4 ZNF22 RIOK1 UBE2O RSL1D1 POP1 BMS1 NAP1L1 MRPS33 KRI1 AATF CHD3 NKTR KRR1 ZBTB11 RPS27L KNOP1 | 3.62e-14 | 571 | 69 | 19 | int:RPL17 |
| Interaction | RPL4 interactions | USP36 SART3 GTPBP4 ZNF22 RIOK1 RSL1D1 TRIM56 POP1 BRD7 BMS1 MRPS33 NSD1 KRI1 AATF CHD3 KRR1 ZBTB11 IFI16 GNL3 RPS27L KNOP1 | 5.27e-14 | 764 | 69 | 21 | int:RPL4 |
| Interaction | RPL7A interactions | USP36 SART3 GTPBP4 ZNF22 RIOK1 UBE2O ATRX RSL1D1 TRIM56 POP1 BRD7 BMS1 NAP1L1 KRI1 AATF CHD3 KRR1 IFI16 RPS27L KNOP1 | 6.63e-14 | 679 | 69 | 20 | int:RPL7A |
| Interaction | RPL31 interactions | USP36 GTPBP4 RIOK1 UBE2O RSL1D1 NKAPD1 POP1 BMS1 NAP1L1 NSD1 NAP1L4 KRI1 AATF CHD3 KRR1 ZBTB11 GNL3 RPS27L KNOP1 | 8.06e-13 | 680 | 69 | 19 | int:RPL31 |
| Interaction | H2AC17 interactions | SART3 GTPBP4 UBE2O POP1 BMS1 NAP1L1 MRPS33 NAP1L4 KRI1 AATF KRR1 ZBTB11 KNOP1 | 9.73e-13 | 232 | 69 | 13 | int:H2AC17 |
| Interaction | PPAN interactions | USP36 GTPBP4 ZNF22 RIOK1 RSL1D1 ZNF644 BRD7 KRR1 ZBTB11 IFI16 GNL3 KNOP1 | 2.31e-12 | 193 | 69 | 12 | int:PPAN |
| Interaction | RPL19 interactions | USP36 SART3 GTPBP4 ZNF22 RIOK1 UBE2O RSL1D1 POP1 BMS1 NAP1L1 KRI1 AATF CHD3 KRR1 ZBTB11 GNL3 RPS27L KNOP1 | 3.08e-12 | 638 | 69 | 18 | int:RPL19 |
| Interaction | FBL interactions | USP36 GTPBP4 RIOK1 UBE2O RSL1D1 NKAPD1 ZNF644 POP1 BMS1 NAP1L1 NAP1L4 KRI1 AATF CHD3 KRR1 PHIP GNL3 KNOP1 | 3.16e-12 | 639 | 69 | 18 | int:FBL |
| Interaction | PARP1 interactions | USP36 GTPBP4 UBE2O MED19 ARID4B VPS72 RSL1D1 NKAPD1 ZNF644 TRIM56 POP1 BRD7 BMS1 FAM169A NAP1L1 NSD1 KRI1 AATF CHD3 IFI16 PHIP AP3D1 GNL3 KNOP1 | 3.93e-12 | 1316 | 69 | 24 | int:PARP1 |
| Interaction | NOP56 interactions | USP36 GTPBP4 ATRX RSL1D1 NKAPD1 POP1 BRD7 BMS1 NAP1L1 NSD1 KRI1 AATF CHD3 KRR1 IFI16 GNL3 KNOP1 | 5.72e-12 | 570 | 69 | 17 | int:NOP56 |
| Interaction | POLR1G interactions | USP36 GTPBP4 ARID4B VPS72 RSL1D1 ZNF644 BRPF1 BMS1 NSD1 KRI1 AATF CHD8 ZBTB11 PHIP GNL3 KNOP1 | 6.64e-12 | 489 | 69 | 16 | int:POLR1G |
| Interaction | H2BC8 interactions | RIOK1 UBE2O ARID4B VPS72 ATRX ZNF644 BRPF1 BRD7 BMS1 FAM169A NAP1L1 NSD1 CHD8 CHD3 PHIP RPS27L KNOP1 | 6.75e-12 | 576 | 69 | 17 | int:H2BC8 |
| Interaction | RPS6 interactions | USP36 GTPBP4 ZNF22 RIOK1 UBE2O RSL1D1 NKAPD1 POP1 BRD7 BMS1 NAP1L1 KRI1 AATF CHD3 KRR1 ZBTB11 PHIP GNL3 RPS27L KNOP1 | 6.90e-12 | 874 | 69 | 20 | int:RPS6 |
| Interaction | SMC5 interactions | USP36 SART3 MED19 ARID4B VPS72 ATRX RSL1D1 ZNF644 BRD7 NSD1 KRI1 AATF CHD8 CHD3 ZDBF2 KRR1 JMJD1C PHIP GNL3 RPS27L KNOP1 | 9.19e-12 | 1000 | 69 | 21 | int:SMC5 |
| Interaction | POLR1E interactions | USP36 GTPBP4 VPS72 ZNF644 BMS1 NSD1 KRI1 AATF CHD8 ZDBF2 KRR1 ZBTB11 IFI16 KNOP1 | 1.14e-11 | 350 | 69 | 14 | int:POLR1E |
| Interaction | H3C1 interactions | USP36 GTPBP4 RIOK1 ARID4B ATRX RSL1D1 ZNF644 BRPF1 POP1 BRD7 NAP1L1 NSD1 KRI1 CHD8 CHD3 KRR1 JMJD1C PHIP GNL3 KNOP1 | 1.20e-11 | 901 | 69 | 20 | int:H3C1 |
| Interaction | H2BC21 interactions | SART3 LONP1 ZNF22 RIOK1 USF3 ARID4B VPS72 ATRX ZNF644 BRPF1 BRD7 NAP1L1 NSD1 NAP1L4 CHD8 IFI16 JMJD1C PHIP | 1.30e-11 | 696 | 69 | 18 | int:H2BC21 |
| Interaction | GLI4 interactions | 1.46e-11 | 125 | 69 | 10 | int:GLI4 | |
| Interaction | RPL3 interactions | USP36 SART3 GTPBP4 ZNF22 RIOK1 RSL1D1 TRIM56 POP1 BRD7 BMS1 KRI1 IFIT5 AATF CHD3 KRR1 ZBTB11 IFI16 KNOP1 | 2.38e-11 | 722 | 69 | 18 | int:RPL3 |
| Interaction | RPL6 interactions | USP36 SART3 GTPBP4 RIOK1 UBE2O RSL1D1 BRD7 NAP1L1 MRPS33 KRI1 AATF CHD3 KRR1 ZBTB11 IFI16 GNL3 RPS27L | 3.28e-11 | 637 | 69 | 17 | int:RPL6 |
| Interaction | SNRNP40 interactions | USP36 VPS72 PRPF40B RSL1D1 NKAPD1 ZNF644 POP1 BMS1 KRI1 AATF CHD3 ZDBF2 NKTR ZBTB11 MED12 GNL3 KNOP1 | 3.28e-11 | 637 | 69 | 17 | int:SNRNP40 |
| Interaction | RPL36AL interactions | USP36 ZNF22 RIOK1 UBE2O POP1 NAP1L1 MRPS33 NAP1L4 KRI1 AATF KRR1 GNL3 KNOP1 | 3.60e-11 | 309 | 69 | 13 | int:RPL36AL |
| Interaction | COIL interactions | USP36 SART3 GTPBP4 LONP1 RIOK1 RSL1D1 NKAPD1 ZNF644 BRPF1 BMS1 NSD1 CHD8 CHD3 ZBTB11 IFI16 KNOP1 | 4.05e-11 | 552 | 69 | 16 | int:COIL |
| Interaction | RPLP0 interactions | USP36 GTPBP4 ZNF22 RIOK1 UBE2O RSL1D1 TRIM56 POP1 BRD7 BMS1 KRI1 AATF CHD3 KRR1 ZBTB11 IFI16 KNOP1 | 5.70e-11 | 660 | 69 | 17 | int:RPLP0 |
| Interaction | PES1 interactions | USP36 GTPBP4 RIOK1 UBE2O POP1 BRD7 NAP1L1 NAP1L4 AATF KRR1 IFI16 GNL3 | 6.93e-11 | 258 | 69 | 12 | int:PES1 |
| Interaction | ADARB1 interactions | USP36 SART3 GTPBP4 ZNF22 RSL1D1 NKAPD1 POP1 BMS1 AATF CHD8 CHD3 NKTR ZBTB11 GNL3 KNOP1 | 8.19e-11 | 489 | 69 | 15 | int:ADARB1 |
| Interaction | H3C3 interactions | GTPBP4 RIOK1 UBE2O ATRX NKAPD1 ZNF644 BRPF1 BRD7 FAM169A NSD1 CHD8 CHD3 JMJD1C PHIP KNOP1 | 9.71e-11 | 495 | 69 | 15 | int:H3C3 |
| Interaction | RPL13A interactions | USP36 SART3 GTPBP4 ZNF22 RIOK1 RSL1D1 TRIM56 POP1 BMS1 KRI1 AATF CHD3 NKTR KRR1 ZBTB11 KNOP1 | 1.11e-10 | 591 | 69 | 16 | int:RPL13A |
| Interaction | MEN1 interactions | SART3 GTPBP4 ATRX RSL1D1 ZNF644 BRPF1 POP1 BMS1 NAP1L1 KRI1 AATF CHD8 CHD3 KRR1 IFI16 JMJD1C AP3D1 MED12 RPS27L KNOP1 | 1.29e-10 | 1029 | 69 | 20 | int:MEN1 |
| Interaction | FTSJ3 interactions | USP36 SART3 RIOK1 UBE2O RSL1D1 VPS13C BRD7 NAP1L4 AATF CHD3 KRR1 IFI16 GNL3 KNOP1 | 1.36e-10 | 422 | 69 | 14 | int:FTSJ3 |
| Interaction | NEIL1 interactions | GTPBP4 ZNF22 RSL1D1 POP1 BMS1 MRPS33 KRI1 AATF KRR1 ZBTB11 GNL3 KNOP1 | 1.51e-10 | 276 | 69 | 12 | int:NEIL1 |
| Interaction | AURKAIP1 interactions | GTPBP4 LONP1 UBE2O ARID4B NAP1L1 MRPS33 NAP1L4 KRI1 CHD3 KRR1 GNL3 KNOP1 | 2.10e-10 | 284 | 69 | 12 | int:AURKAIP1 |
| Interaction | RBM19 interactions | USP36 ZNF22 RIOK1 RSL1D1 BMS1 KRI1 AATF KRR1 ZBTB11 IFI16 KNOP1 | 2.24e-10 | 221 | 69 | 11 | int:RBM19 |
| Interaction | SIRT6 interactions | SART3 GTPBP4 TXLNA VPS72 ATRX RSL1D1 ZNF644 POP1 BRD7 AATF CHD8 CHD3 ZDBF2 NKTR ZBTB11 MED12 | 2.70e-10 | 628 | 69 | 16 | int:SIRT6 |
| Interaction | NPM1 interactions | USP36 SART3 GTPBP4 ZNF22 RSL1D1 POP1 BRD7 BMS1 NAP1L1 NSD1 NAP1L4 KRI1 AATF CHD8 CHD3 KRR1 ZBTB11 SYT7 GNL3 RPS27L KNOP1 | 2.76e-10 | 1201 | 69 | 21 | int:NPM1 |
| Interaction | H1-3 interactions | ZNF22 RIOK1 ATRX RSL1D1 POP1 BMS1 NSD1 KRI1 AATF KRR1 IFI16 KNOP1 | 2.77e-10 | 291 | 69 | 12 | int:H1-3 |
| Interaction | RPL8 interactions | USP36 GTPBP4 TXLNA RIOK1 UBE2O RSL1D1 POP1 BRD7 BMS1 NAP1L1 AATF CHD3 ZBTB11 IFI16 KNOP1 | 3.17e-10 | 539 | 69 | 15 | int:RPL8 |
| Interaction | SIRT7 interactions | SART3 GTPBP4 LONP1 UBE2O RSL1D1 POP1 BMS1 NAP1L1 NSD1 KRI1 AATF CHD8 KRR1 ZBTB11 PHIP MED12 GNL3 | 3.63e-10 | 744 | 69 | 17 | int:SIRT7 |
| Interaction | RNF151 interactions | 3.64e-10 | 123 | 69 | 9 | int:RNF151 | |
| Interaction | SRSF4 interactions | ZNF22 RIOK1 RSL1D1 NKAPD1 BRD7 BMS1 AATF NKTR KRR1 ZBTB11 IFI16 KNOP1 | 3.93e-10 | 300 | 69 | 12 | int:SRSF4 |
| Interaction | CENPA interactions | USP36 GTPBP4 ATRX ZNF644 BRPF1 BRD7 BMS1 NSD1 KRI1 AATF CHD3 PHIP KNOP1 | 4.20e-10 | 377 | 69 | 13 | int:CENPA |
| Interaction | H1-4 interactions | USP36 GTPBP4 TXLNA RIOK1 RSL1D1 TRIM56 POP1 BMS1 NSD1 KRI1 AATF CHD3 KRR1 ZBTB11 IFI16 BRWD3 | 5.10e-10 | 656 | 69 | 16 | int:H1-4 |
| Interaction | RPS2 interactions | USP36 GTPBP4 ZNF22 RIOK1 UBE2O RSL1D1 BRD7 BMS1 KRI1 AATF CHD3 KRR1 ZBTB11 IFI16 RPS27L KNOP1 | 5.21e-10 | 657 | 69 | 16 | int:RPS2 |
| Interaction | NOP58 interactions | USP36 GTPBP4 RIOK1 UBE2O RSL1D1 BRD7 AATF CHD3 KRR1 IFI16 MED12 GNL3 | 5.51e-10 | 309 | 69 | 12 | int:NOP58 |
| Interaction | GNL2 interactions | USP36 GTPBP4 RIOK1 RSL1D1 NKAPD1 BRD7 AATF PRPF38B CHD3 KRR1 IFI16 GNL3 KNOP1 | 5.60e-10 | 386 | 69 | 13 | int:GNL2 |
| Interaction | SRSF5 interactions | GTPBP4 ZNF22 RIOK1 UBE2O RSL1D1 POP1 BRD7 BMS1 KRI1 CHD3 KRR1 ZBTB11 IFI16 KNOP1 | 6.21e-10 | 474 | 69 | 14 | int:SRSF5 |
| Interaction | H1-2 interactions | USP36 ZNF22 RIOK1 UBE2O USF3 ATRX RSL1D1 POP1 BRD7 BMS1 NSD1 KRI1 AATF CHD3 KRR1 IFI16 | 6.35e-10 | 666 | 69 | 16 | int:H1-2 |
| Interaction | NHLH1 interactions | 6.43e-10 | 88 | 69 | 8 | int:NHLH1 | |
| Interaction | ZNF574 interactions | SART3 GTPBP4 UBE2O RSL1D1 BMS1 MRPS33 KRI1 KRR1 ZBTB11 IFI16 KNOP1 | 7.01e-10 | 246 | 69 | 11 | int:ZNF574 |
| Interaction | RSL1D1 interactions | USP36 RIOK1 UBE2O RSL1D1 BRD7 BMS1 NSD1 AATF CHD3 NKTR KRR1 ZBTB11 IFI16 KNOP1 | 7.12e-10 | 479 | 69 | 14 | int:RSL1D1 |
| Interaction | MNDA interactions | 8.29e-10 | 188 | 69 | 10 | int:MNDA | |
| Interaction | PRKRA interactions | GTPBP4 ZNF22 RSL1D1 TRIM56 POP1 BMS1 IFIT5 AATF KRR1 ZBTB11 IFI16 GNL3 KNOP1 | 8.64e-10 | 400 | 69 | 13 | int:PRKRA |
| Interaction | EBNA1BP2 interactions | USP36 GTPBP4 RIOK1 RSL1D1 POP1 BRD7 AATF CHD3 KRR1 IFI16 GNL3 KNOP1 | 9.45e-10 | 324 | 69 | 12 | int:EBNA1BP2 |
| Interaction | FGFBP1 interactions | USP36 GTPBP4 ZNF22 TRIM56 POP1 BRD7 BMS1 KRI1 AATF KRR1 KNOP1 | 1.11e-09 | 257 | 69 | 11 | int:FGFBP1 |
| Interaction | REXO4 interactions | USP36 GTPBP4 ZNF22 RIOK1 RSL1D1 POP1 KRI1 CHD3 KRR1 IFI16 KNOP1 | 1.31e-09 | 261 | 69 | 11 | int:REXO4 |
| Interaction | RPL36 interactions | USP36 GTPBP4 ZNF22 RIOK1 UBE2O RSL1D1 TRIM56 POP1 BMS1 NSD1 AATF CHD3 NKTR KNOP1 | 1.37e-09 | 504 | 69 | 14 | int:RPL36 |
| Interaction | NOP2 interactions | USP36 SART3 GTPBP4 ZNF22 RSL1D1 BRD7 BMS1 AATF CHD3 KRR1 IFI16 GNL3 KNOP1 | 1.39e-09 | 416 | 69 | 13 | int:NOP2 |
| Interaction | RPL23A interactions | USP36 GTPBP4 RIOK1 UBE2O POP1 BMS1 NAP1L1 MRPS33 NSD1 NAP1L4 KRI1 CHD3 KRR1 RPS27L KNOP1 | 1.58e-09 | 606 | 69 | 15 | int:RPL23A |
| Interaction | RPL18 interactions | USP36 SART3 GTPBP4 ZNF22 RIOK1 UBE2O RSL1D1 ZNF644 NAP1L1 MRPS33 NAP1L4 CHD3 GNL3 RPS27L | 1.68e-09 | 512 | 69 | 14 | int:RPL18 |
| Interaction | ABT1 interactions | USP36 GTPBP4 ZNF22 RIOK1 UBE2O RSL1D1 BMS1 MRPS33 KRI1 AATF KRR1 ZBTB11 KNOP1 | 1.70e-09 | 423 | 69 | 13 | int:ABT1 |
| Interaction | RPS3 interactions | USP36 SART3 RIOK1 ZNF273 RSL1D1 BRD7 BMS1 NAP1L1 KRI1 AATF CHD3 KRR1 ZBTB11 IFI16 GNL3 RPS27L | 1.99e-09 | 721 | 69 | 16 | int:RPS3 |
| Interaction | RPSA interactions | USP36 GTPBP4 RIOK1 UBE2O RSL1D1 POP1 BMS1 KRI1 AATF CHD3 KRR1 ZBTB11 IFI16 RPS27L | 2.15e-09 | 522 | 69 | 14 | int:RPSA |
| Interaction | RPSA2 interactions | 2.40e-09 | 152 | 69 | 9 | int:RPSA2 | |
| Interaction | NOL12 interactions | 2.54e-09 | 153 | 69 | 9 | int:NOL12 | |
| Interaction | RPS24 interactions | USP36 GTPBP4 RIOK1 UBE2O RSL1D1 ZNF644 BMS1 KRI1 AATF CHD3 KRR1 GNL3 RPS27L KNOP1 | 2.56e-09 | 529 | 69 | 14 | int:RPS24 |
| Interaction | SUPT16H interactions | USP36 RIOK1 UBE2O ATRX RSL1D1 BRD7 NAP1L1 KRI1 CHD3 NKTR IFI16 PHIP GNL3 | 2.89e-09 | 442 | 69 | 13 | int:SUPT16H |
| Interaction | GTPBP4 interactions | USP36 SART3 GTPBP4 RIOK1 UBE2O POP1 BRD7 AATF CHD3 KRR1 IFI16 JMJD1C GNL3 | 2.97e-09 | 443 | 69 | 13 | int:GTPBP4 |
| Interaction | HECTD1 interactions | GTPBP4 TXLNA MED19 ARID4B RSL1D1 POP1 BMS1 NAP1L1 KRI1 AATF PRPF38B CHD3 KRR1 ZBTB11 AP3D1 MED12 GNL3 KNOP1 | 3.47e-09 | 984 | 69 | 18 | int:HECTD1 |
| Interaction | SNRNP70 interactions | GTPBP4 ZNF22 RIOK1 UBE2O RSL1D1 POP1 BMS1 NAP1L1 MRPS33 KRI1 PRPF38B CHD3 NKTR KRR1 IFI16 GNL3 RPS27L KNOP1 | 3.47e-09 | 984 | 69 | 18 | int:SNRNP70 |
| Interaction | ZBTB2 interactions | GTPBP4 ZNF22 UBE2O RSL1D1 POP1 BMS1 NAP1L1 KRI1 CHD3 NKTR KRR1 PHIP GNL3 | 3.58e-09 | 450 | 69 | 13 | int:ZBTB2 |
| Interaction | RPS8 interactions | USP36 SART3 GTPBP4 RIOK1 RSL1D1 BRD7 MRPS33 KRI1 AATF CHD3 KRR1 IFI16 GNL3 RPS27L KNOP1 | 4.00e-09 | 649 | 69 | 15 | int:RPS8 |
| Interaction | RPL11 interactions | USP36 GTPBP4 RIOK1 UBE2O RSL1D1 TRIM56 BMS1 NAP1L1 AATF CHD3 KRR1 ZBTB11 GNL3 RPS27L KNOP1 | 4.26e-09 | 652 | 69 | 15 | int:RPL11 |
| Interaction | H2AZ1 interactions | USP36 RIOK1 ARID4B VPS72 ZNF644 BRD7 NAP1L1 NSD1 NAP1L4 CHD8 JMJD1C PHIP | 4.35e-09 | 371 | 69 | 12 | int:H2AZ1 |
| Interaction | RPS3A interactions | SART3 GTPBP4 ZNF22 RIOK1 RSL1D1 BRD7 BMS1 NAP1L1 AATF CHD3 KRR1 IFI16 MED12 RPS27L KNOP1 | 4.53e-09 | 655 | 69 | 15 | int:RPS3A |
| Interaction | ZC3H3 interactions | 4.92e-09 | 226 | 69 | 10 | int:ZC3H3 | |
| Interaction | MYBBP1A interactions | USP36 GTPBP4 ZNF22 UBE2O RSL1D1 POP1 BRD7 BMS1 AATF CHD3 KRR1 IFI16 KNOP1 | 5.04e-09 | 463 | 69 | 13 | int:MYBBP1A |
| Interaction | ZNF346 interactions | GTPBP4 ZNF22 UBE2O RSL1D1 TRIM56 POP1 BMS1 KRI1 AATF KRR1 ZBTB11 KNOP1 | 5.21e-09 | 377 | 69 | 12 | int:ZNF346 |
| Interaction | MAST1 interactions | 5.35e-09 | 228 | 69 | 10 | int:MAST1 | |
| Interaction | ILF3 interactions | USP36 GTPBP4 ZNF22 RIOK1 RSL1D1 TRIM56 POP1 BRD7 BMS1 NSD1 AATF CHD3 KRR1 IFI16 GNL3 RPS27L KNOP1 | 6.02e-09 | 896 | 69 | 17 | int:ILF3 |
| Interaction | DDX56 interactions | USP36 GTPBP4 RIOK1 UBE2O POP1 BRD7 AATF CHD3 KRR1 IFI16 USP33 | 6.44e-09 | 304 | 69 | 11 | int:DDX56 |
| Interaction | KIF23 interactions | GTPBP4 LONP1 TXLNA UBE2O RSL1D1 TRIM56 BMS1 NAP1L1 NSD1 KRI1 AATF PRPF38B CHD3 KRR1 IFI16 PHIP GNL3 RPS27L | 7.19e-09 | 1031 | 69 | 18 | int:KIF23 |
| Interaction | WDR46 interactions | 7.48e-09 | 173 | 69 | 9 | int:WDR46 | |
| Interaction | DDX23 interactions | USP36 GTPBP4 RSL1D1 NKAPD1 BRPF1 BMS1 KRI1 AATF CHD3 NKTR IFI16 GNL3 KNOP1 | 7.75e-09 | 480 | 69 | 13 | int:DDX23 |
| Interaction | H1-7 interactions | 1.01e-08 | 179 | 69 | 9 | int:H1-7 | |
| Interaction | RPL10 interactions | USP36 GTPBP4 RIOK1 UBE2O POP1 MRPS33 KRI1 AATF CHD3 KRR1 ZBTB11 IFI16 PHIP GNL3 KNOP1 | 1.15e-08 | 702 | 69 | 15 | int:RPL10 |
| Interaction | IFI16 interactions | USP36 SART3 GTPBP4 RIOK1 RSL1D1 TRIM56 POP1 BMS1 KRI1 AATF KRR1 IFI16 PHIP GNL3 KNOP1 | 1.44e-08 | 714 | 69 | 15 | int:IFI16 |
| Interaction | H1-1 interactions | GTPBP4 ZNF22 RSL1D1 POP1 BMS1 NAP1L1 NAP1L4 KRI1 AATF KRR1 ZBTB11 GNL3 KNOP1 | 1.48e-08 | 507 | 69 | 13 | int:H1-1 |
| Interaction | DDX21 interactions | USP36 SART3 GTPBP4 ZNF22 RIOK1 RSL1D1 POP1 BRD7 BMS1 KRI1 AATF CHD3 KRR1 IFI16 MED12 | 1.55e-08 | 718 | 69 | 15 | int:DDX21 |
| Interaction | DDX18 interactions | USP36 GTPBP4 UBE2O RSL1D1 BRD7 AATF CHD3 KRR1 KMT2E IFI16 GNL3 | 1.70e-08 | 334 | 69 | 11 | int:DDX18 |
| Interaction | RPS16 interactions | USP36 GTPBP4 ZNF22 RIOK1 RSL1D1 POP1 BMS1 KRI1 AATF CHD3 KRR1 ZBTB11 GNL3 RPS27L KNOP1 | 1.73e-08 | 724 | 69 | 15 | int:RPS16 |
| Interaction | RPL23AP32 interactions | 1.90e-08 | 87 | 69 | 7 | int:RPL23AP32 | |
| Interaction | SURF6 interactions | USP36 GTPBP4 ZNF22 RIOK1 RSL1D1 POP1 BMS1 KRI1 AATF KRR1 IFI16 GNL3 | 2.02e-08 | 426 | 69 | 12 | int:SURF6 |
| Interaction | KLF12 interactions | 2.03e-08 | 194 | 69 | 9 | int:KLF12 | |
| Cytoband | 12q21.2 | 4.28e-04 | 20 | 70 | 2 | 12q21.2 | |
| Cytoband | 15q22.2 | 9.06e-04 | 29 | 70 | 2 | 15q22.2 | |
| Cytoband | Xq21.1 | 1.17e-03 | 33 | 70 | 2 | Xq21.1 | |
| GeneFamily | PHD finger proteins | 4.13e-05 | 90 | 39 | 4 | 88 | |
| GeneFamily | Synaptotagmins | 6.04e-04 | 17 | 39 | 2 | 765 | |
| GeneFamily | PWWP domain containing | 1.02e-03 | 22 | 39 | 2 | 1147 | |
| GeneFamily | Cyclins|Mediator complex | 2.29e-03 | 33 | 39 | 2 | 1061 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 2.44e-03 | 34 | 39 | 2 | 487 | |
| GeneFamily | X-linked mental retardation|Angiotensin receptors | 5.83e-03 | 53 | 39 | 2 | 103 | |
| GeneFamily | Ubiquitin specific peptidases | 6.49e-03 | 56 | 39 | 2 | 366 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | ARID4B ATRX VPS13C ZNF644 NAP1L1 NSD1 NAP1L4 PHTF2 KRI1 CHSY1 PRPF38B CHD3 KMT2E IFI16 JMJD1C PHIP | 1.49e-06 | 1492 | 70 | 16 | M40023 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | ZNF22 ARID4B VPS13C ZNF644 NAP1L1 PRPF38B NKTR KRR1 ZBTB11 IFI16 | 9.24e-06 | 656 | 70 | 10 | M18979 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_DN | USP36 GTPBP4 USF3 ZNF644 FAM169A CHSY1 IFIT5 KRR1 SIPA1L2 KMT2E JMJD1C | 1.38e-05 | 844 | 70 | 11 | M41129 |
| Coexpression | FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL | 6.97e-05 | 380 | 70 | 7 | M41703 | |
| Coexpression | ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP | 8.65e-05 | 687 | 70 | 9 | M41022 | |
| Coexpression | ZHENG_CORD_BLOOD_C7_PUTATIVE_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_1 | 1.29e-04 | 96 | 70 | 4 | M39216 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN | 1.53e-04 | 189 | 70 | 5 | M8275 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 1.54e-04 | 432 | 70 | 7 | M41149 | |
| Coexpression | GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_DN | 1.57e-04 | 190 | 70 | 5 | M8457 | |
| Coexpression | GSE6875_TCONV_VS_TREG_UP | 1.90e-04 | 198 | 70 | 5 | M6799 | |
| Coexpression | GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP | 1.90e-04 | 198 | 70 | 5 | M6123 | |
| Coexpression | GSE369_IFNG_KO_VS_WT_LIVER_UP | 1.95e-04 | 199 | 70 | 5 | M5970 | |
| Coexpression | GSE3039_ALPHAALPHA_VS_ALPHABETA_CD8_TCELL_DN | 1.99e-04 | 200 | 70 | 5 | M6475 | |
| Coexpression | GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP | 1.99e-04 | 200 | 70 | 5 | M6477 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_UP | 1.99e-04 | 200 | 70 | 5 | M4524 | |
| Coexpression | GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN | 1.99e-04 | 200 | 70 | 5 | M9260 | |
| Coexpression | GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_UP | 1.99e-04 | 200 | 70 | 5 | M5668 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | GTPBP4 RIOK1 UBE2O ARID4B ATRX NKAPD1 ASTE1 NAP1L4 PRPF38B ZBTB11 JMJD1C BRWD3 | 2.06e-07 | 564 | 68 | 12 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | ZNF22 ARID4B ATRX RSL1D1 NKAPD1 ZNF644 POP1 BRD7 FAM169A MRPS33 NSD1 PRPF38B ZDBF2 PHIP GNL3 BRWD3 RPS27L | 2.55e-07 | 1241 | 68 | 17 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | SART3 GTPBP4 USF3 ARID4B ATRX RSL1D1 ASTE1 FAM169A PRPF38B ZDBF2 FAM181B PHIP GNL3 KNOP1 | 2.42e-06 | 989 | 68 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | ZNF22 ARID4B ATRX RSL1D1 NKAPD1 ZNF644 POP1 BRD7 FAM169A MRPS33 NSD1 PRPF38B ZDBF2 PHIP GNL3 BRWD3 RPS27L | 2.62e-06 | 1468 | 68 | 17 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | USP36 UBE2O RSL1D1 NKAPD1 BRD7 FAM169A NAP1L1 PHTF2 PRPF38B ZDBF2 KRR1 SYT7 PHIP GNL3 BRWD3 KNOP1 | 5.00e-06 | 1371 | 68 | 16 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | BMP3 VPS13C TRIM56 FAM169A PRPF38B CHD8 ZDBF2 FAM181B SIPA1L2 KMT2E PHIP | 6.76e-06 | 654 | 68 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | UBE2O ARID4B ATRX BRD7 ASTE1 FAM169A NAP1L4 PRPF38B PHIP BRWD3 | 3.00e-05 | 629 | 68 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | ZNF22 ARID4B ATRX RSL1D1 NKAPD1 ZNF644 BRD7 FAM169A NAP1L1 NSD1 PRPF38B ZDBF2 PHIP GNL3 | 3.66e-05 | 1257 | 68 | 14 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 4.81e-05 | 532 | 68 | 9 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | USP36 GTPBP4 ZNF273 RSL1D1 FAM169A NAP1L1 PRPF38B ZDBF2 FAM181B KRR1 SYT7 GNL3 KNOP1 | 7.07e-05 | 1164 | 68 | 13 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.13e-04 | 595 | 68 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | ZNF22 ARID4B ATRX RSL1D1 NKAPD1 ZNF644 BRD7 FAM169A NAP1L1 NSD1 PRPF38B ZDBF2 PHIP GNL3 | 1.81e-04 | 1459 | 68 | 14 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500 | 1.81e-04 | 496 | 68 | 8 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.09e-04 | 169 | 68 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | BMP3 MED19 ATRX STK32B PRPF38B CHD8 CHD3 ZDBF2 ZMAT1 PHIP KNOP1 | 2.77e-04 | 986 | 68 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | USP36 GTPBP4 ZNF273 RSL1D1 FAM169A NAP1L1 PRPF38B ZDBF2 FAM181B KRR1 SYT7 GNL3 KNOP1 | 3.02e-04 | 1347 | 68 | 13 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.80e-04 | 311 | 68 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#5_top-relative-expression-ranked_100 | 5.46e-04 | 11 | 68 | 2 | gudmap_developingGonad_e14.5_ epididymis_100_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#4 | 5.59e-04 | 587 | 68 | 8 | Facebase_RNAseq_e8.5_Floor Plate_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | ZNF729 UBE2O ARID4B ATRX RSL1D1 NKAPD1 ZNF644 BRD7 FAM169A NSD1 PRPF38B BRWD3 | 5.65e-04 | 1252 | 68 | 12 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 6.35e-04 | 328 | 68 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#4 | 6.76e-04 | 124 | 68 | 4 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K4 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.56e-13 | 200 | 70 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.59e-08 | 183 | 70 | 7 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.91e-08 | 188 | 70 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.21e-08 | 192 | 70 | 7 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.29e-08 | 193 | 70 | 7 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-4|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.48e-07 | 166 | 70 | 6 | 52293b8a74d46e6161fb6a2e7e86e51fd9e89a5b | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.32e-07 | 189 | 70 | 6 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.39e-07 | 195 | 70 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 6.78e-07 | 197 | 70 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.98e-07 | 198 | 70 | 6 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.98e-07 | 198 | 70 | 6 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 7.19e-07 | 199 | 70 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.19e-07 | 199 | 70 | 6 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.34e-06 | 135 | 70 | 5 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.52e-06 | 176 | 70 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.00e-06 | 178 | 70 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 188 | 70 | 5 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 195 | 70 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 195 | 70 | 5 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 1.43e-05 | 196 | 70 | 5 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 1.43e-05 | 196 | 70 | 5 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.47e-05 | 197 | 70 | 5 | ef2d1f56acd0be43e69bba7f73f6909ba87f1cb3 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.47e-05 | 197 | 70 | 5 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.47e-05 | 197 | 70 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.51e-05 | 198 | 70 | 5 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.51e-05 | 198 | 70 | 5 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.51e-05 | 198 | 70 | 5 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 1.54e-05 | 199 | 70 | 5 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.54e-05 | 199 | 70 | 5 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.58e-05 | 200 | 70 | 5 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 1.58e-05 | 200 | 70 | 5 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Inner_Medullary_Collecting_Duct_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.04e-05 | 145 | 70 | 4 | 6f6e08b1234a08f94bd17c11d267f39eabb10068 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 8.94e-05 | 149 | 70 | 4 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | normal-na-Lymphocytic_T-T4_reg-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.26e-04 | 163 | 70 | 4 | 43887e7687fc6367efac0c1f56a9534b06f47b7f | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 178 | 70 | 4 | 09d2687e0d79f12e90af35fc1c0453d249cf2d19 | |
| ToppCell | normal-na-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.77e-04 | 178 | 70 | 4 | fa3585383a1e7da460c88a802aaa81246d681b6b | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 183 | 70 | 4 | 24db9cc717e651586317c6a8e03a3401651273c1 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 183 | 70 | 4 | 92ef926e6c1de8477fa4f35d1dae85482d8009de | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-04 | 184 | 70 | 4 | e7b9c69fc77040c5191ad8089697051e2589c30e | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-04 | 184 | 70 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 185 | 70 | 4 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | droplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 186 | 70 | 4 | 26f1e9930adf2fe4af0819e56f69915bd8330e4a | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.10e-04 | 186 | 70 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-04 | 187 | 70 | 4 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.14e-04 | 187 | 70 | 4 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.27e-04 | 190 | 70 | 4 | f623f0bdece6002b68ac2207e99408b24a2b1194 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 190 | 70 | 4 | 52c59001a079c76249abbaa3141e9e661b83d9a0 | |
| ToppCell | Calu_3-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.32e-04 | 191 | 70 | 4 | 2da876d26f37a00dbdf1ee79d724306e8b20f304 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.32e-04 | 191 | 70 | 4 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.32e-04 | 191 | 70 | 4 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 191 | 70 | 4 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.36e-04 | 192 | 70 | 4 | 35557254738844c27ffcd00f3287fbcc0a4d0f3b | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.36e-04 | 192 | 70 | 4 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | HSPCs-Ery_prog.|World / Lineage and Cell class | 2.41e-04 | 193 | 70 | 4 | 484c2e0daedc6cb0d50d164add8c1658123a60f9 | |
| ToppCell | COVID-19_Convalescent-PLT_4|COVID-19_Convalescent / Disease Group and Platelet Clusters | 2.46e-04 | 194 | 70 | 4 | ce1fad4e76a87f0c35e430ed1f2262395df882fd | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-04 | 194 | 70 | 4 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.51e-04 | 195 | 70 | 4 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | normal-na-Lymphocytic_T-T4_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.56e-04 | 196 | 70 | 4 | feb1c768cf66c64b6c892905d2d865946e70812f | |
| ToppCell | moderate-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.56e-04 | 196 | 70 | 4 | 9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da | |
| ToppCell | mild-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.56e-04 | 196 | 70 | 4 | ded44b38ea489946e9eedfe752b5a9fde9149c16 | |
| ToppCell | tumor_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|tumor_Lung / Location, Cell class and cell subclass | 2.61e-04 | 197 | 70 | 4 | de26ca046038e34790cece24529a05d491e6f8ef | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.66e-04 | 198 | 70 | 4 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 2.66e-04 | 198 | 70 | 4 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.66e-04 | 198 | 70 | 4 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | (1)_T_cell-(11)_Activated_CD4_T|(1)_T_cell / shred on Cell_type and subtype | 2.66e-04 | 198 | 70 | 4 | 4b9ad91342f622c63e476d4f6a0ae5bf282a7ef5 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.66e-04 | 198 | 70 | 4 | 33a3b279c9ff3b762e52d060dae062167ca2239b | |
| ToppCell | Mild/Remission-B_naive-9|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.71e-04 | 199 | 70 | 4 | e9af3c6a05f435ac8d7066f54feb653012b51ffb | |
| ToppCell | Enterocyte_Progenitors|World / shred on cell type and cluster | 2.71e-04 | 199 | 70 | 4 | 776bcc887927dea9ebd76ec4338ce2225c319c2c | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.71e-04 | 199 | 70 | 4 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 2.71e-04 | 199 | 70 | 4 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | Healthy/Control|World / Disease group and Cell class | 2.71e-04 | 199 | 70 | 4 | 2623c42b3e79e401a485879b52e8bbcbc581544d | |
| ToppCell | mLN-T_cell-Tfh|T_cell / Region, Cell class and subclass | 2.71e-04 | 199 | 70 | 4 | a234f14ff46a0dc2f916a80e1e7af7d793006050 | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.71e-04 | 199 | 70 | 4 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 2.71e-04 | 199 | 70 | 4 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | severe-CD8+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.76e-04 | 200 | 70 | 4 | 61c7c08460856c188e62edf1fa62855578146fc8 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 2.76e-04 | 200 | 70 | 4 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| Computational | Neighborhood of CDC10 | 8.55e-05 | 146 | 54 | 6 | MORF_CDC10 | |
| Computational | Neighborhood of USP5 | 1.29e-04 | 52 | 54 | 4 | MORF_USP5 | |
| Computational | Neighborhood of CUL1 | 4.54e-04 | 72 | 54 | 4 | MORF_CUL1 | |
| Drug | Baclofen (R,S) [1134-47-0]; Down 200; 18.8uM; HL60; HG-U133A | 2.39e-06 | 196 | 70 | 7 | 2036_DN | |
| Drug | Amoxapine [14028-44-5]; Down 200; 12.8uM; PC3; HG-U133A | 2.47e-06 | 197 | 70 | 7 | 1931_DN | |
| Drug | Bromocryptine mesylate [22260-51-1]; Down 200; 5.4uM; PC3; HG-U133A | 2.95e-05 | 194 | 70 | 6 | 1925_DN | |
| Drug | Perphenazine [58-39-9]; Down 200; 10uM; PC3; HG-U133A | 3.04e-05 | 195 | 70 | 6 | 1956_DN | |
| Drug | R(+)-verapamil hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 3.22e-05 | 197 | 70 | 6 | 164_DN | |
| Disease | Macrocephaly | 1.91e-06 | 11 | 68 | 3 | C0221355 | |
| Disease | Intellectual Disability | 7.64e-05 | 447 | 68 | 7 | C3714756 | |
| Disease | Adenoid Cystic Carcinoma | 8.56e-05 | 100 | 68 | 4 | C0010606 | |
| Disease | N-acetyl-beta-alanine measurement | 6.15e-04 | 16 | 68 | 2 | EFO_0021430 | |
| Disease | malignant astrocytoma (is_marker_for) | 1.28e-03 | 23 | 68 | 2 | DOID:3069 (is_marker_for) | |
| Disease | Mental Retardation, X-Linked | 2.04e-03 | 29 | 68 | 2 | C1136249 | |
| Disease | fibrinogen measurement | 2.06e-03 | 109 | 68 | 3 | EFO_0004623 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KKKQTKRAKHKINPV | 341 | Q7L8C5 | |
| NVPKIKHRKKIKNKL | 631 | Q4LE39 | |
| KSKNKKKQRKGPHRK | 331 | P12645 | |
| PLFHKKKGNRKKLVE | 2281 | Q9HCK8 | |
| KQHKKAKKRKSLGAP | 151 | Q6ZW13 | |
| RKRKKRKKGEKQIPG | 61 | Q9NPI1 | |
| MKPKHLLSGKRKAGK | 616 | Q9BZE4 | |
| ERQKKPKQTRKKKGG | 896 | Q6RI45 | |
| HEKPSQKRVKKLRKK | 656 | Q9P1Z9 | |
| QKKHRKKNSGPKAAK | 6 | Q14692 | |
| LPKGRSNSKKKRQKK | 621 | Q2TB18 | |
| KPKKKKHRKEKEERT | 871 | O14617 | |
| KSKQPKFRSIKCKHK | 781 | Q96L73 | |
| KTIKKKQKHKGRGTV | 271 | P55209 | |
| TVKTIKKKQKHKGRG | 261 | Q99733 | |
| KKKQKHKGRGTVRTI | 266 | Q99733 | |
| PKGKNKHLMNKRRKP | 341 | Q15652 | |
| KRRKKSGEKEQHISK | 226 | Q8IZD2 | |
| KRKSPREHNGKVKKK | 201 | Q1ED39 | |
| KKREAPLTGKKKRKS | 466 | Q8N9T8 | |
| FKHKNVNKRKEPKKK | 246 | Q13601 | |
| NKHKPRRKSKRGKKE | 231 | P36776 | |
| ERKKKSTKGKKRSQP | 1781 | Q93074 | |
| LDKPGKSKRKVNHRK | 81 | A6NEQ2 | |
| QKEKKKREKRQKPGR | 911 | Q99575 | |
| KSPGKGRKKIRKILK | 1471 | P46100 | |
| HTDKRKKKGRKIPKL | 16 | A0AVF1 | |
| KKATHNRPKGKDKLK | 301 | Q13325 | |
| KKAHHDKKPSRKKQG | 146 | P0C671 | |
| DKKPSRKKQGHKKHA | 151 | P0C671 | |
| GVKKRKRGPKKQKEN | 46 | Q12873 | |
| NLRRKAKGHKGPAKK | 651 | Q9Y6X4 | |
| KLKVKGPALSRKRKK | 86 | Q16666 | |
| KLRKEAKKRGHKKPR | 31 | Q9BVP2 | |
| GKRLKKTPEKKTGNK | 146 | O43405 | |
| LKKKKKIRGPEKRGA | 611 | Q15020 | |
| PKKKNKHKHKQSRTQ | 171 | A0JLT2 | |
| RKNKIPKHVKKRKEK | 546 | Q9BRS2 | |
| EQKRLKKLRGKEKPK | 81 | Q9Y291 | |
| KEKPKKGEGKRAAKR | 91 | Q9Y291 | |
| PDKKHKLETKVKRKN | 181 | O43581 | |
| KLGLRNKPKKTAHVK | 71 | Q8N3S3 | |
| KDKKHKAPKRKQAFH | 1001 | P30414 | |
| KKKHKKKRLVQSPNS | 16 | Q71UM5 | |
| IVQKAHRKMRKTKPK | 106 | O75343 | |
| KKKEKVKPRKDAHLF | 836 | Q9P2F8 | |
| EKQSPELVKKHKKKR | 506 | Q13438 | |
| PKSGKHKNKEKRKDS | 146 | P55201 | |
| IHKKVDRKASKGRKL | 501 | Q9NY61 | |
| KKHKGKKMTVPVRRH | 456 | Q86X52 | |
| TRKGKQPHKRKKKSR | 196 | Q6ZUT1 | |
| QPHKRKKKSRKKSLK | 201 | Q6ZUT1 | |
| HKKRQTGKKPFKCKE | 196 | Q14593 | |
| HKGMEKKLQKRKAVP | 521 | O95625 | |
| SGEIIHKKRGRKPKK | 1651 | Q8WWQ0 | |
| HKKRGRKPKKLQYAK | 1656 | Q8WWQ0 | |
| KKEQTPEHGKKKRGR | 336 | O76021 | |
| KKKKRRCGQKVEKPE | 4371 | Q15413 | |
| KKREHSPSKEKSRKR | 486 | Q5VTL8 | |
| KHKRKKNKITRDFKP | 526 | Q9C0C9 | |
| KGRQVHLKHKKRKPS | 606 | Q9HCK1 | |
| DIKPGRKRKKHKKHF | 146 | Q709C8 | |
| GADHGLRKAKKPKKK | 771 | Q6NWY9 | |
| KPKKKTKKRRHKSNS | 781 | Q6NWY9 | |
| KSKRLNKKPGGRKHL | 791 | Q68DE3 | |
| QVKRVKKPKGDHKKT | 841 | Q96AE7 | |
| PHSKIGLEKKRKRKM | 281 | Q9H582 | |
| AKQPAKKKRKKGLRI | 56 | P86452 | |
| MKVHKEEKPRKTRGK | 186 | P17026 | |
| ESKPLHKKKKRLAKN | 321 | Q9NY57 | |
| DKKKQVHKKRKCPGP | 196 | Q15906 | |
| ATAAPHGKRKRKKKK | 836 | Q9P275 | |
| HGKRKRKKKKRPEDT | 841 | Q9P275 | |
| KAQSASPKRKKQHKK | 456 | Q8TEY7 | |
| RPNKKKKFKGRLKSI | 456 | Q9BRZ2 | |
| HRRPQEKKKAKGLGK | 156 | P40222 | |
| RKHKIIHTGKKPYKR | 336 | A6NN14 | |
| GKLKHRKKKKSHDVP | 591 | Q5H9K5 |